Local Analgesia in Knee- and Hipatroplastic Surgery in Patients With Rheumatic Disease: Extra- vs. Intracapsulare Position of Catheter

Sponsor
Spenshult Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT01050738
Collaborator
(none)
72
1
2
7
10.3

Study Details

Study Description

Brief Summary

Postoperative pain is part of surgery trauma. In orthopedic surgery artroplastic replacement of knee- and hipjoints are common. Postoperative pain relieve can be complicated. A new concept for pain relieve postoperative is local infiltration analgesia (LIA). This technique implicates that a catheter is left in the surgical area and that local anestesia can be administered post surgery. The goal is no or only little pain with minimal side effects. The catheter could be placed intra- or extracapsulare. The best position is not known. Primary aim is to study if position of the catheter effects the need of other postoperative analgesia. Secondary aim is to study if the position effects patient mobility within the first two days.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Position of catheter
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
72 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Local Analgesia in Knee- and Hipatroplastic Surgery in Patients With Rheumatic Disease: Extra- vs. Intracapsulare Position of Catheter
Study Start Date :
Jan 1, 2010
Anticipated Primary Completion Date :
Aug 1, 2010
Anticipated Study Completion Date :
Aug 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Intracapsulare position

Procedure: Position of catheter
Position of catheter for administration of local anestesia.

Active Comparator: Extracapsulare position

Procedure: Position of catheter
Position of catheter for administration of local anestesia.

Outcome Measures

Primary Outcome Measures

  1. Need for other postoperative analgesia. [48 hours]

Secondary Outcome Measures

  1. Patient mobility within the first 48 hours. [48 hours]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients undergoing arthroplastic surgery of knee or hip
Exclusion Criteria:
  • Sensitivity to local anesthetics

  • Other reason not to use local anesthetics

Contacts and Locations

Locations

Site City State Country Postal Code
1 Spenshult Hospital Oskarström Sweden SE-31392

Sponsors and Collaborators

  • Spenshult Hospital

Investigators

  • Study Chair: Stefan Bergman, MD, PhD, R&D-center Spenshult

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01050738
Other Study ID Numbers:
  • FOUS09002
First Posted:
Jan 15, 2010
Last Update Posted:
Aug 18, 2010
Last Verified:
Aug 1, 2010
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 18, 2010